CDK7 CLIA Kit

Produktnummer ABIN5668847

Produktdetails CDK7 CLIA Kit

Target: CDK7 (Cyclin-Dependent Kinase 7 (CDK7))

Reaktivität: Human

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.313 mU/mL - 20 mU/mL

Untere Nachweisgrenze: 0.313 mU/mL

Applikation: ELISA

Analytische Methode: Quantitative

Sensitivität: 0.188 mU/mL

Bestandteile: - Micro CLIA Plate
- Reference Standard
- Concentrated Biotinylated Detection Ab (100×)
- Concentrated HRP Conjugate (100×)
- Reference Standard & Sample Diluent
- Biotinylated Detection Ab Diluent
- HRP Conjugate Diluent
- Concentrated Wash Buffer (25×)
- Substrate Reagent A
- Substrate Reagent B
- Plate Sealer
- Product Description
- Certificate of Analysis

Anwendungsinformationen

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: The unopened kit can be stored at 4 ℃ for 1 week. If the kit is not used within 1 week, store the items separately according to the special conditions since the kit is received.

Antigendetails

Target: CDK7 (Cyclin-Dependent Kinase 7 (CDK7))

Andere Bezeichnung: Cyclin Dependent Kinase 7 (CDK7 Produkte)

Synonyme: CAK1 CLIA Kit, CDKN7 CLIA Kit, HCAK CLIA Kit, MO15 CLIA Kit, STK1 CLIA Kit, p39MO15 CLIA Kit, AI323415 CLIA Kit, AI528512 CLIA Kit, C230069N13 CLIA Kit, Cdkn7 CLIA Kit, Crk4 CLIA Kit, CD 7 CLIA Kit, CDK7 CLIA Kit, CG3319 CLIA Kit, DmCDK7 CLIA Kit, DmCdk7 CLIA Kit, DmMO15 CLIA Kit, DmMo15 CLIA Kit, Dmcdk7 CLIA Kit, Dmel\\CG3319 CLIA Kit, Mo15 CLIA Kit, cdk-7 CLIA Kit, cdk7 CLIA Kit, dCdk7 CLIA Kit, p40[MO15] CLIA Kit, p40MO15 CLIA Kit, stk1 CLIA Kit, zgc:85821 CLIA Kit, cak1 CLIA Kit, cdkn7 CLIA Kit, p39mo15 CLIA Kit, cyclin dependent kinase 7 CLIA Kit, cyclin-dependent kinase 7 CLIA Kit, Cyclin-dependent kinase 7 CLIA Kit, cyclin-dependent kinase 7 L homeolog CLIA Kit, CDK7 CLIA Kit, Cdk7 CLIA Kit, cdk7.L CLIA Kit, cdk7 CLIA Kit

Pathways: Zellzyklus, DNA Reparatur, Intracellular Steroid Hormone Receptor Signaling Pathway, Mitotic G1-G1/S Phases, M Phase